ASRM - Ospedale di Termoli (Spoke)
- Address
- Viale S. Francesco, 1, 86039 Termoli, Italy
ASRM - Ospedale di Termoli: Breast Cancer Research Center
ASRM - Ospedale di Termoli (Spoke) is a specialized research facility focused on advancing the treatment of hormone-responsive malignancies. The center plays a vital role in investigating optimal treatment strategies for endocrine-responsive breast cancer, with particular emphasis on therapeutic sequencing and timing in post-menopausal patient populations.
- Adjuvant chemotherapy optimization in early breast cancer
- Aromatase inhibitor therapy and treatment sequencing
- Endocrine-responsive tumor management strategies
The center's research addresses critical clinical questions regarding the integration of chemotherapy and endocrine therapy in breast cancer treatment. With approximately 80% of breast cancers classified as endocrine-responsive, the facility's work on determining whether concurrent or sequential administration of these therapies yields better outcomes has significant implications for disease recurrence prevention and long-term patient care in women across North America, Europe, and Latin America.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Consorzio Oncotech1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ASRM - Ospedale di Termoli (Spoke)
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Menstrual Bleeding Patterns, Tolerability, and Compliance with Norgestimate and Ethinylestradiol in Italian Women Using Monophasic Oral Contraceptives | Italfarmaco S.p.A. | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 8 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Anastrozole | 1 | Unknown | 2025-02-03 | 2025-02-03 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.